Disease-modifying drug therapies

Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep:5 Suppl 1:68-75. doi: 10.1080/17434470410019898.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Age Factors
  • Age of Onset
  • Amyotrophic Lateral Sclerosis / complications
  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / epidemiology
  • Amyotrophic Lateral Sclerosis / mortality
  • Antirheumatic Agents / therapeutic use
  • Bulbar Palsy, Progressive / drug therapy
  • Bulbar Palsy, Progressive / etiology
  • Cohort Studies
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Neuroprotective Agents / therapeutic use
  • Retrospective Studies
  • Riluzole / therapeutic use*
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Neuroprotective Agents
  • Riluzole